Embody vs TMates
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Embody
Best for lowest first-month entry pricing on compounded GLP-1sStarting at $99/mo
TMates
Best for nationwide compounded GLP-1 availability including Puerto RicoStarting at $199/mo
Side-by-Side Comparison
| Feature | Embody | TMates |
|---|---|---|
| Overall Score | ✓8.5/10 | 6.3/10 |
| Starting Price | ✓$99/mo | $199/mo |
| Editorial Rating | ✓4.3 ★ /5 | 3.2 ★ /5 |
| Features | ✓6 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Embody
Pros
- ✓Lowest first-month entry pricing in the compounded segment ($99 first month for semaglutide, $149 for tirzepatide injection)
- ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- ✓Available in all 50 states with no insurance friction
- ✓24/7 unlimited clinician messaging and dose-adjustment support included
- ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Cons
- ✗Refill pricing jumps to $299/month after the first month — initial $99/$149 is an intro rate, not the ongoing cost
- ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — compounding source transparency is limited
- ✗Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
TMates
Pros
- ✓All-inclusive monthly pricing covers medication, consultations, nutrition coaching, and 24/7 support with no separate membership fee
- ✓Available in all 50 US states plus Puerto Rico and other US territories
- ✓Both compounded semaglutide and tirzepatide offered
- ✓Fast stated turnaround (intake to medication delivery in 2–3 days)
Cons
- ✗No disclosed third-party accreditations (no verified LegitScript, PCAB, ACHC, or NABP) — weaker pharmacy-oversight signal than competitors
- ✗BBB rating B+ (not accredited) with 8 complaints filed, most involving billing and cancellation friction
- ✗Trustpilot reviews show partial-refund and contact-difficulty reports, and some customer posts allege reviews have been removed
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Pharmacy partners not publicly named — TMates explicitly disclaims both medical practice and pharmacy dispensing responsibility, routing both to independent third parties
- ✗Also sells Schedule III testosterone products and other wellness SKUs alongside GLP-1s — worth knowing about for readers who want a GLP-1-focused provider
Our Verdict
Embody edges out TMates with a higher overall score of 8.5/10 and is particularly strong for lowest first-month entry pricing on compounded GLP-1s. TMates remains a solid alternative, especially if you're looking for nationwide compounded GLP-1 availability including Puerto Rico.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.